Zymeworks מכפיל רווח שנתי 2024

מה עושה Zymeworks?

Zymeworks Inc is a biotechnology company that was founded in 2003. The company is headquartered in Vancouver, Canada. The founders of the company were a group of researchers specializing in the development of antibodies. Their goal was to develop a platform technology that allows for the design and production of highly specific and effective antibodies. Zymeworks Inc's platform technology is based on the use of protein engineering technologies such as Immunoglobulin G competences (IgG). This allows for the targeted production of antibodies that bind to specific target molecules. The business model of Zymeworks Inc is based on licensing its platform technology to other companies. The licensees use Zymeworks' platform to develop antibodies or other proteins for their own pharmaceutical research. Zymeworks Inc has various business areas that specialize in the different applications of its platform technology. This includes cancer immunotherapy, the treatment of autoimmune diseases, and the development of biological therapeutics. The company also offers products that can be used directly by patients, such as a test kit for determining the risk of breast cancer. Over the years, Zymeworks Inc has expanded its business areas and formed partnerships with major pharmaceutical companies. In summary, Zymeworks Inc is a leading biotechnology company specializing in the development of antibodies and other proteins. It has a unique platform technology that allows its customers to develop targeted antibodies and therapeutic proteins. Its products are used in various areas, including cancer immunotherapy, the treatment of autoimmune diseases, and biological therapeutics. Zymeworks ist eines der beliebtesten Unternehmen auf Eulerpool.com.